Search

everythinglearnresearchcommunity

for

Search:↓

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Children with classic congenital adrenal hyperplasia have thicker heart fat and are at higher risk for heart problems and early atherosclerosis.

Lower irisin levels in the blood may indicate more severe acne.

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

High Lipid Accumulation Product levels are linked to more hirsutism in women with Polycystic Ovary Syndrome.

Children with classic congenital adrenal hyperplasia have thicker heart fat and more heart and blood vessel risk factors, especially if their condition is not well-controlled.

Inositol was more effective than Metformin in treating symptoms of PCOS in women.

Inositol was more effective than metformin in improving menstrual cycles and pregnancy rates in PCOS patients.

Men with early hair loss may have higher health risks similar to women with PCOS.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Probiotics and synbiotics may help with PCOS symptoms, but more research is needed.

Testosterone therapy improved physical and social health in a male with 49,XXXXY syndrome.

Skin issues in PCOS signal hormone problems, and combined treatments improve outcomes.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Women with PCOS often have insulin resistance, abnormal lipid levels, and a higher risk of diabetes and heart disease; lifestyle changes and medication like metformin can help manage these risks.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Anorexia Nervosa and Bulimia Nervosa are complex eating disorders with increasing incidence among young females, significant morbidity, and varying mortality rates, requiring more research for better treatment.

PCOS treatment should be personalized based on individual symptoms and health goals.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

Quercetin may help with PCOS symptoms, but more research is needed.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Women with PCOS have altered brain structure and reduced cognitive performance.